Background Fetal alcohol spectrum disorder (FASD) is a leading preventable cause of
neurodevelopmental disability in North America. The stigma associated with alcohol use …

Background Although fetal alcohol spectrum disorders represent a significant public health
problem, Native Americans are underrepresented in population and targeted screening …

Challenges in identifying children exposed prenatally to ethanol necessitate the
development of a biomarker for neonates at risk for fetal alcohol spectrum disorder …

Meconium fatty acid ethyl esters (FAEEs) are sensitive and specific biomarkers for prenatal
alcohol exposure (PAE) in pregnancy. We recently reported a 2.5% rate of FAEE positive …

OBJECTIVE: To test the sensitivity and specificity of fatty acid ethyl esters (FAEEs) extracted
from meconium to identify alcohol-using pregnant women with a sensitive and specific …

Prenatal alcohol exposure can lead to a wide range of deficits known as fetal alcohol
spectrum disorder. Epidemiologic studies regarding alcohol consumption in pregnancy have …

Meconium fatty acid ethyl esters (FAEEs) are validated biomarkers of fetal alcohol exposure.
Meconium FAEE testing can potentially be used as a screen by health-care professionals to …

Our study aimed to estimate the prevalence of heavy fetal alcohol exposure through the
analysis of meconium FAEEs as an objective biomarker of fetal exposure. We conducted a …

Prenatal alcohol exposure (PAE) continues to be a serious public health problem, yet no
reliable clinical tools are available for assessing levels of drinking during pregnancy. Fatty …

Background Mediators of susceptibility to alcohol-related toxicity in the prenatal environment
are relatively unknown. The placenta has been proposed as a potential source of variability …